It is forthcoming, that American Hongshang Investment Group and the most authoritative COMPANION genetic detection center in Houston, Texas, will apply the world’s top genetic detection equipment and technology from Zhuangyimei Health Investment Management Group Co., Ltd.; to carry out physical health genetic analysis, early warning detection, and intervention and treatment for the healthy and sub-healthy person. COMPANION Laboratories Inc. was founded in 2009 and formally established in June 2011. The company is the first laboratory to use “oral swabbing”, replacing the conventional method of “blood drawing”. It has developed PDx drug detection methods, which has an authoritative position and was promoted by doctors and experts across the US in a very short period of time. It has become the latest generation of bio-tech leaders. The company provides the most advanced and efficient genetic detection equipment. It is reflective in its science and technology and standard processes, and the conduct of molecular diagnostic tests, including genetic detection of drugs (PGx) and cancer detection (CDx). Drug genetic detection is used to analyze the change in reactions of individual genes to a drug. Cancer detection is used to analyze gene mutation; analysis of cancer cells to help doctors determine the appropriate medical approach. Introduced by professional managers, in May, 2012, the genetic detection method was officially put on a trial test, as businesses continued developing across different cities in the U.S. From June of that year, in just one month, it received universal support from various medical clinics and doctors who became the most loyal customer base; just as more customers in need were expanding, they were recommended and introduced to the lab.